Description
Pharmacological effect
Propecia 1 mg is designed to treat androgenic baldness, which affects approximately 10% of the male population of different ages. The activation of hair growth is due to the high testosterone content. Npecia also treats hyperplasia and its symptoms. The substance finasteride changes the hormonal pattern in local points and has a directional effect on the condition of the hair follicles. Npecia contains synthetic nitrogen-based inhibitory compounds, which represent intracellular enzymes of the 5a-reductase type, which ensure the conversion of testosterone to dihydrotestosterone.
Indications for use
Effective treatment of baldness in men.
Application procedure
Npecia is available in tablets with an active enzyme content of 1 mg finasteride. Standard reception: 1 tablet a day with water, regardless of food intake. Results appear after 5-6 single doses. Duration of hospitalization: no more than 3 months, which is enough to stop hair loss and death of the bulbs, as well as their recovery and recovery. After the interruption, about 12 months pass before returning to the original result. Then a course of treatment is required. The tablets are designed for internal use without contact of the internal composition with the external environment and are taken without chewing, entirely.
Contraindications
Npecia is contraindicated in children and pregnant women, with sensitivity to the components of the drug, men – with liver, kidney, prostate, with allergies. It should be noted that Finasteride (Propecia) 1 mg is not intended to treat the symptoms of androgenetic alopecia during the postmenopausal period in women.
Adverse events:
Clinically negative reactions were not detected. Npecia can cause such side effects as erectile dysfunction, decreased vision, rash and inflammation on the skin, headache and dizziness, swelling of the face and lips, pain in the testicles due to the oppression of testosterone. All undesirable effects disappear after discontinuation of the drug.
Reviews
There are no reviews yet.